November 18, 2015
Advanced Oncotherapy disposes of its subsiadiary for £100K
Advanced Oncotherapy has disposed of its subsidiary, Oncotherapy Resources Ltd (ORL), for a total cash consideration of £100,000 to Xstrahl.…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
November 18, 2015
FDA grants Breakthrough Therapy designation to Avelumab for treating Merkel cell carcinoma
The US Food and Drug Administration (FDA) has granted avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Breakthrough…
November 18, 2015
Anavex prepares for regulatory filings based on FDA guidance
Anavex is moving forward with the development program for ANAVEX 2-73 for the treatment of Alzheimer’s disease in a…
November 18, 2015
AmerisourceBergen in managerial changes. Adoption of proxy access
Steven H. Collis, the President and Chief Executive Officer (CEO) of AmerisourceBergen Corporation will succeed Richard C. Gozon as Chairman of the Board
November 18, 2015
Vertex gets EU approval for expanded use of its cystic fibrosis drug Kalydeco
The European Commission has approved expansion of the indication for Vertex Pharmaceuticals’ Kalydeco, to include children ages 2-5 with cystic fibrosis…
November 18, 2015
Hikma’s Portugal facility in compliance with US FDA
Hikma’s Portuguese facility back into compliance with the US FDA.
November 18, 2015
FDA accepts Sandoz regulatory submission for a biosimilar of cancer drug pegfilgrastim
The US Food and Drug Administration (FDA) has accepted Sandoz’s Biologics License Application (BLA) for its proposed biosimilar to Amgen’s US-licensed Neulasta (pegfilgrastim) – a recombinant human granulocyte colony-stimulating factor (G-CSF).
November 18, 2015
French academic Xavier Darcos to preside Sanofi
Sanofi has appointed Xavier Darcos as President of the Sanofi Espoir Foundation, who succeeds Jean-François Dehecq. Under Dehecq’s Presidency, According to the…
November 17, 2015
Allergan and CDC to raise awareness of the threat of antibiotic resistance
Allergan has joined forces with CDC to spread the word about Antibiotic Stewardship During “Get Smart About Antibiotics Week.” According…
November 17, 2015
Mylan launches generic version of Axert in US. $1B share repurchase plan authorized
Mylan N.V. has launch Almotriptan Tablets USP, 6.25 mg and 12.5 mg, the generic version of Janssen Pharmaceutical’s AXERT in the U.S.…